Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- fosphenytoin
- sucralfate
Interactions between your drugs
sucralfate fosphenytoin
Applies to: sucralfate, fosphenytoin
ADJUST DOSING INTERVAL: Sucralfate may interfere with the absorption of oral phenytoin and may reduce its therapeutic effect. Sucralfate may interact in a similar way with other oral hydantoins.
MANAGEMENT: Patients should be advised to take phenytoin at least two hours before or 6 hours after sucralfate and to notify their physician if loss of seizure control occurs.
References (3)
- McCarthy DM (1991) "Sucralfate." N Engl J Med, 325, p. 1017-25
- Smart HL, Somerville KW, Williams J, et al. (1985) "The effects of sucralfate upon phenytoin absorption in man." Br J Clin Pharmacol, 20, p. 238-40
- (2001) "Product Information. Carafate (sucralfate)." Hoechst Marion Roussel
Drug and food interactions
sucralfate food
Applies to: sucralfate
ADJUST DOSING INTERVAL: The administration of sucralfate with enteral nutrition may result in precipitation and the formation of bezoars that may obstruct feeding tubes. The proposed mechanism is the formation of an insoluble aluminum-protein complex between the aluminum in the sucralfate and the protein in the enteral feeding. In addition, sucralfate may not become activated due to the alkaline pH of enteral nutrition products.
MANAGEMENT: Some experts recommend separating the sucralfate doses from enteral feedings by at least 1 hour. Alternatively, consideration may be given to proton pump inhibitors or H2 antagonists.
References (1)
- Wohlt PD, Zheng L, Gunderson S, Balzar SA, Johnson BD, Fish JT (2009) "Recommendations for the use of medications with continuous enteral nutrition." Am J Health Syst Pharm, 66, p. 1438-67
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Lamictal
Lamictal is an anti-epileptic medication used treat seizures in adults and children over 2 years ...
Lyrica
Lyrica is used to control seizures, treat nerve pain and fibromyalgia. Learn about side effects ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Depakote
Depakote is used to treat various types of seizure disorders. Learn about side effects ...
Ativan
Ativan is a benzodiazepine used to treat anxiety disorders or anxiety associated with depression ...
Keppra
Keppra is an anti-epileptic drug used to treat partial onset seizures in people with epilepsy ...
Klonopin
Klonopin (clonazepam) is used to control seizures in epilepsy and for the treatment of panic ...
Topamax
Topamax (topiramate) is used to prevent seizures in adults and children and to prevent migraine ...
Valium
Valium is used to treat anxiety disorders, alcohol withdrawal symptoms, or muscle spasms. Learn ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.